These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15869963)
21. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Hu P; Arias RS; Sadun RE; Nien YC; Zhang N; Sabzevari H; Lutsiak ME; Khawli LA; Epstein AL Clin Cancer Res; 2008 Jan; 14(2):579-88. PubMed ID: 18223234 [TBL] [Abstract][Full Text] [Related]
22. Characterization of bioactive recombinant woodchuck interleukin-2 amplified by RLM-RACE and produced in eukaryotic expression system. Gujar SA; Michalak TI Vet Immunol Immunopathol; 2006 Aug; 112(3-4):183-98. PubMed ID: 16631932 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene. Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317 [TBL] [Abstract][Full Text] [Related]
24. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats. Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582 [TBL] [Abstract][Full Text] [Related]
25. Biological hydrogen production by Clostridium acetobutylicum in an unsaturated flow reactor. Zhang H; Bruns MA; Logan BE Water Res; 2006 Feb; 40(4):728-34. PubMed ID: 16427113 [TBL] [Abstract][Full Text] [Related]
26. Targeted gene disruption by use of a group II intron (targetron) vector in Clostridium acetobutylicum. Shao L; Hu S; Yang Y; Gu Y; Chen J; Yang Y; Jiang W; Yang S Cell Res; 2007 Nov; 17(11):963-5. PubMed ID: 17971808 [No Abstract] [Full Text] [Related]
27. Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo. Shi M; Zhang L; Gu HT; Jiang FQ; Qian L; Yu M; Chen GJ; Luo Q; Shen BF; Guo N Acta Pharmacol Sin; 2007 Oct; 28(10):1611-20. PubMed ID: 17883948 [TBL] [Abstract][Full Text] [Related]
28. [Construction and expression of an anti-GD2,ScFv-IL-2 fusion protein gene]. Ni J; Ji J; Lü A; Huang R; Wei Y; Wu W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):170-5. PubMed ID: 17333916 [TBL] [Abstract][Full Text] [Related]
29. Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan. Farrar MD; Whitehead TR; Lan J; Dilger P; Thorpe R; Holland KT; Carding SR J Appl Microbiol; 2005; 98(5):1191-7. PubMed ID: 15836489 [TBL] [Abstract][Full Text] [Related]
30. Functional expression of the lipase gene Lip2 of Pleurotus sapidus in Escherichia coli. Zelena K; Krügener S; Lunkenbein S; Zorn H; Berger RG Biotechnol Lett; 2009 Mar; 31(3):395-401. PubMed ID: 18982247 [TBL] [Abstract][Full Text] [Related]
31. Complete activity profile of Clostridium acetobutylicum [FeFe]-hydrogenase and kinetic parameters for endogenous redox partners. Demuez M; Cournac L; Guerrini O; Soucaille P; Girbal L FEMS Microbiol Lett; 2007 Oct; 275(1):113-21. PubMed ID: 17681007 [TBL] [Abstract][Full Text] [Related]
32. Secretion of biologically active porcine interleukin-2 by Lactococcus lactis. Avall-Jääskeläinen S; Palva A Vet Microbiol; 2006 Jun; 115(1-3):278-83. PubMed ID: 16549279 [TBL] [Abstract][Full Text] [Related]
33. A Bacillus subtilis fusion protein system to produce soybean Bowman-Birk protease inhibitor. Vogtentanz G; Collier KD; Bodo M; Chang JH; Day AG; Estell DA; Falcon BC; Ganshaw G; Jarnagin AS; Kellis JT; Kolkman MA; Lai CS; Meneses R; Miller JV; de Nobel H; Power S; Weyler W; Wong DL; Schmidt BF Protein Expr Purif; 2007 Sep; 55(1):40-52. PubMed ID: 17574434 [TBL] [Abstract][Full Text] [Related]
34. Molecular cloning and expression of the trichoderma harzianum C4 endo-beta-1,4-Xylanase Gene in Saccharomyces cerevisiae. Lee JM; Shin JW; Nam JK; Choi JY; Jeong CS; Han IS; Nam SW; Choi YJ; Chung DK J Microbiol Biotechnol; 2009 Aug; 19(8):823-8. PubMed ID: 19734721 [TBL] [Abstract][Full Text] [Related]
35. Biobutanol: an attractive biofuel. Dürre P Biotechnol J; 2007 Dec; 2(12):1525-34. PubMed ID: 17924389 [TBL] [Abstract][Full Text] [Related]
36. Propionate-regulated high-yield protein production in Escherichia coli. Lee SK; Keasling JD Biotechnol Bioeng; 2006 Apr; 93(5):912-8. PubMed ID: 16333863 [TBL] [Abstract][Full Text] [Related]
37. A novel fusion protein system for the production of native human pepsinogen in the bacterial periplasm. Malik A; Rudolph R; Söhling B Protein Expr Purif; 2006 Jun; 47(2):662-71. PubMed ID: 16600627 [TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy. Mårlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291 [TBL] [Abstract][Full Text] [Related]
39. Increasing the secretion ability of the kil gene for recombinant proteins in Escherichia coli by using a strong stationary-phase promoter. Beshay U; Miksch G; Friehs K; Flaschel E Biotechnol Lett; 2007 Dec; 29(12):1893-901. PubMed ID: 17653622 [TBL] [Abstract][Full Text] [Related]
40. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies. Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]